New research presented at the American College of Cardiology's 74th Annual Scientific Session and Expo offers an important ...

Men who participate in high-volume endurance exercise have greater atherosclerotic risk vs. nonathletes and women who ...

Late-Breaking Clinical Trial Presented at the American College of Cardiology Supports Low-Dose Colchicine, 0.5 mg to Treat Cardiovascular Disease by Reducing Progression of Coronary Plaque EKSTROM ...

Presented at: American College of Cardiology Scientific Session ... in either group in the primary outcome of low attenuation plaque (P = .344), but the key secondary outcome of total plaque ...

The condition is “high-risk” plaque, once narrowly defined as plaque built up in the arteries that is likely to rupture, possibly leading to an acute heart attack or sudden cardiac death.

EKSTROM trial results demonstrate low-dose colchicine, 0.5 mg significantly reduced total plaque volume in stable ... clinical trial at the American College of Cardiology 74th Annual Scientific ...